Background Diabetes is a risk factor for cancer in the general population. However, few data is available on the association between post-transplant diabetes mellitus (PTDM) and cancer after transplantation. Methods We analyzed this issue in a Spanish cohort of patients without diabetes before transplantation. PTDM was diagnosed with consensus criteria at 12 months after transplantation and 12 months before the diagnosis of cancer. The association between PTDM and cancer (overall and specific types) was evaluated with regression analysis. Results During a follow-up of 12 years (IQR:8–14), 85 cases of 603 developed cancer (829/100 000/year) and 164 (27%) PTDM. The most frequent cancers were renal cell cancer (RCC) n = 15; 146/cases/100 000/year), lung (n = 12, 117/cases/100 000/year); colon (n = 9, 88/cases/100 000/year) and prostate (n = 9, 88/cases/100 000/year). In logistic regression, PTDM was not associated with cancer. Eight of the 164 patients with PTDM (4.9%) vs. 7 of the 439 without PTDM developed RCC (1.6%): p = 0.027. In multivariate analysis, PTDM was independently associated with RCC (OR: 2.92, CI:1.03–8.27), adjusting for smoking (OR:4.020, CI:1.34–12.02) and other covariates. PTDM was not associated with other types of cancer. Conclusions Patients with PTDM must be considered a population at risk for RCC and accordingly, susceptible of active surveillance.

Conclusions:We found a correlation between the phase angle and uncontrolled nighttime systolic blood pressure, a phenomenon that acts as a cardiovascular risk factor even in patients with daytime blood pressure control. It is important to carry out monitoring studies of blood pressure using ABPM and measurement of anthropometric variables using BIS to improve the evaluation of this group of high-risk patients.